Edwards Lifesciences (EW) Return on Capital Employed Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -85.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -110.00 |
| Dec 31, 2025 | -115.00 |
| Sep 30, 2025 | -264.00 |
| Jun 30, 2025 | -402.00 |
| Mar 31, 2025 | -347.00 |
| Dec 31, 2024 | -472.00 |
| Sep 30, 2024 | -56.00 |
| Jun 30, 2024 | 9.00 |
| Mar 31, 2024 | -389.00 |
| Dec 31, 2023 | -343.00 |
| Sep 30, 2023 | -671.00 |
| Jun 30, 2023 | -599.00 |
| Mar 31, 2023 | -365.00 |
| Dec 31, 2022 | -303.00 |
| Sep 30, 2022 | -201.00 |
| Jun 30, 2022 | -264.00 |
| Mar 31, 2022 | 888.00 |
| Dec 31, 2021 | 850.00 |
| Sep 30, 2021 | 915.00 |
| Jun 30, 2021 | 1,019.00 |
| Mar 31, 2021 | -787.00 |
| Dec 31, 2020 | -688.00 |
| Sep 30, 2020 | -177.00 |
| Jun 30, 2020 | -152.00 |
| Mar 31, 2020 | 603.00 |
| Dec 31, 2019 | 583.00 |
| Sep 30, 2019 | -726.00 |
| Jun 30, 2019 | -679.00 |
| Mar 31, 2019 | -734.00 |
| Dec 31, 2018 | -1,050.00 |
| Sep 30, 2018 | 304.00 |
| Dec 31, 2017 | 599.00 |
| Dec 31, 2016 | 180.00 |
| Dec 31, 2015 | 205.00 |
| Dec 31, 2014 | -395.00 |
| Dec 31, 2013 | -157.00 |
| Dec 31, 2012 | 1,074.00 |
| Dec 31, 2011 | -252.00 |
| Sep 30, 2011 | -303.00 |